ArticlePharmaceutics2025

Bicomponent Cutaneous Cell Therapy for Early Burn Care: Manufacturing Homogeneity and Epidermis-Structuring Functions of Clinical Grade FE002-SK2 Allogeneic Dermal Progenitor Fibroblasts.

Xi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.